OTCMKTS:VTRLY Vitrolife AB (publ) (VTRLY) Stock Price, News & Analysis $16.39 -1.11 (-6.34%) As of 05/9/2025 10:27 AM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartDividendShort InterestBuy This Stock About Vitrolife AB (publ) Stock (OTCMKTS:VTRLY) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Vitrolife AB (publ) alerts:Sign Up Key Stats Today's Range$16.39▼$16.3950-Day Range$16.39▼$18.0052-Week Range$16.39▼$17.66Volume100 shsAverage Volume150 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company OverviewVitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.Read More… Receive VTRLY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vitrolife AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address VTRLY Stock News HeadlinesReport from Annual General Meeting of Vitrolife AB (publ) | VTRLY Stock NewsApril 30, 2025 | gurufocus.comVitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEAApril 24, 2025 | gurufocus.comHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.May 11, 2025 | Brownstone Research (Ad)Vitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA | VTRLY Stock NewsApril 24, 2025 | gurufocus.comVitrolife AB (publ) Interim report Q1, 2025: Strong performance in EMEA | VTRLY Stock NewsApril 24, 2025 | gurufocus.comVitrolife AB (publ) GAAP EPS of SEK1.02, revenue of SEK 959MJanuary 30, 2025 | seekingalpha.comVitrolife AB (publ) - Interim report Q3, 2023: Profitable growth globally despite headwind in the U.S.October 27, 2023 | finance.yahoo.comVitrolife ABOctober 18, 2023 | wsj.comSee More Headlines VTRLY Stock Analysis - Frequently Asked Questions How have VTRLY shares performed this year? Vitrolife AB (publ)'s stock was trading at $18.7470 on January 1st, 2025. Since then, VTRLY shares have decreased by 12.6% and is now trading at $16.39. View the best growth stocks for 2025 here. How do I buy shares of Vitrolife AB (publ)? Shares of VTRLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today5/11/2025Next Earnings (Estimated)7/17/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolOTCMKTS:VTRLY CIKN/A Webwww.vitrolife.com Phone46-3-17-21-80-00FaxN/AEmployees1,132Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Free Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (OTCMKTS:VTRLY) was last updated on 5/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vitrolife AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Vitrolife AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
